Roy Perlis, MD, MSc is the Director of the
Center for Experimental Drugs and Diagnostics
(CEDD) and Associate Director of the Psychiatric
Genetics Program in Mood and Anxiety Disorders
in the PGH Psychiatry Department. He is
an Associate Professor of Psychiatry at
Harvard Medical School and serves as a consultant
to the American Psychiatric Association’s
bipolar treatment guidelines workshop. He
graduated from Brown University, Harvard
Medical School and Harvard School of Public
Health, and he completed his residency,
chief residency, and clinical/research fellowship
at MGH before joining the faculty.
Dr. Perlis’ research and clinical
work is focused on treatment resistant mood
disorders, including bipolar disorder and
major depressive disorder. Current research
efforts include identifying genetic variations
in populations with mental health disorders,
exploring variations that might predict
treatment response or other behaviors, and
developing cost-effective methods for future
genetics research using algorithms to search
medical record databases.
Dr. Perlis has authored more than 125 articles
reporting original research, as well as
numerous book chapters and reviews. His
research has been supported by awards from
NARSAD, NIMH, NSF, the American Philosophical
Society, the Bowman Family Foundation, and
the Stanley Center for Psychiatric Research,
among others. In 2010 Dr. Perlis was awarded
the Depression and Bipolar Support Alliance's
Klerman Young Investigator Award.
|
